Discovery Laboratories Receives New US Patent for Pulmonary Surfactant Formulations
Published: Jan 17, 2013
WARRINGTON, Pa., Jan. 17, 2013 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) today announced it has received a patent issued by the United States Patent and Trademark Office (USPTO) entitled "Pulmonary Surfactant Formulations." The claims of the patent (U.S. Patent Number 8,337,815) provide coverage for synthetic pulmonary surfactant compositions comprising a combination of a proprietary synthetic peptide and various lipids. The patent term expires in December 2028.